These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Characteristics of the reproductive function in genital endometriosis before and after the use of synthetic progestins]. Shinkareva LF; Nagovitsyna AI; Sabsaĭ MI; Serebrennikova KG Vopr Okhr Materin Det; 1977 Dec; 22(12):60-5. PubMed ID: 341510 [No Abstract] [Full Text] [Related]
24. [Dydrogesterone (Duphaston) in the prevention of risk of ultrasound guided amniocentesis]. Korczyński J Ginekol Pol; 2000 Aug; 71(8):709-13. PubMed ID: 11082907 [TBL] [Abstract][Full Text] [Related]
25. New progestins and potential actions. Negro-Vilar A J Soc Gynecol Investig; 2000; 7(1 Suppl):S53-4. PubMed ID: 10732331 [TBL] [Abstract][Full Text] [Related]
26. The effect of progesterone and progestogens on the foetus. Dalton K Neuropharmacology; 1981 Dec; 20(12B):1267-9. PubMed ID: 7033815 [No Abstract] [Full Text] [Related]
27. [Basic principles of using progestins]. Feldsher Akush; 1980; 45(1):48-54. PubMed ID: 6898488 [No Abstract] [Full Text] [Related]
28. [Etiology of tongue-dependent jaw abnormalities, with special consideration of hormonal factors]. Machtens E; Quakernack K; Westermann W Fortschr Kiefer Gesichtschir; 1974; 18():87-90. PubMed ID: 4534114 [No Abstract] [Full Text] [Related]
29. Experiments on the suppressive effect of a synthetic gestagen on the activity of the pregnant human uterus. BENGTSSON LP Acta Obstet Gynecol Scand; 1962; 41():124-43. PubMed ID: 13867214 [No Abstract] [Full Text] [Related]
30. Proceedings of the Second International Symposium on Progestins, Progesterone Receptor Modulators and Progesterone Antagonists. November 20-23, 2002. Siena, Italy. Steroids; 2003 Nov; 68(10-13):759-1119. PubMed ID: 14667965 [No Abstract] [Full Text] [Related]
31. [Lesions in children of hormone-treated mothers?]. Lauritzen C Dtsch Med Wochenschr; 1977 Oct; 102(43):1569-70. PubMed ID: 913300 [No Abstract] [Full Text] [Related]
32. Therapeutic drugs in pregnancy. Caution is the watchword. Niebyl JR Postgrad Med; 1984 Jun; 75(8):165-6, 169-72. PubMed ID: 6728734 [TBL] [Abstract][Full Text] [Related]
33. Hormone administration during pregnancy and its effect on the offspring. Browne JC Contrib Gynecol Obstet; 1979; 5():. PubMed ID: 365448 [No Abstract] [Full Text] [Related]
34. Progestational drug products for human use; requirements for labeling directed to the patient. Food and Drug Administration, HHS. Final rule. Fed Regist; 1999 Nov; 64(220):62110-2. PubMed ID: 11010691 [TBL] [Abstract][Full Text] [Related]
35. Hormonal versus genetic factors in limb and heart anomalies. el-Gindi E; Ahmed-Nasr M Cardiovasc Surg; 1993 Aug; 1(4):381-3. PubMed ID: 8076064 [TBL] [Abstract][Full Text] [Related]
38. Decreased abortions in HMG-induced pregnancies with prophylactic progesterone therapy. Check JH; Wu CH; Adelson HG Int J Fertil; 1985; 30(3):45-7. PubMed ID: 2867058 [TBL] [Abstract][Full Text] [Related]
39. Abortion: its prediction and management. Use of progestins in patients with arborization of cervical mucus smears. Jacobson BD Fertil Steril; 1965; 16(5):604-12. PubMed ID: 5833968 [No Abstract] [Full Text] [Related]
40. The safety of progesterone and 17-hydroxyprogesterone caproate administration for the prevention of preterm birth: an evidence-based assessment. O'Brien JM Am J Perinatol; 2012 Oct; 29(9):665-72. PubMed ID: 22773279 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]